COMMUNIQUÉS West-GlobeNewswire

Arbutus Announces Decision to Discontinue Development of AB-506, an Oral Capsid Inhibitor for the Treatment of Chronic Hepatitis B

03/10/2019 - 22:05

WARMINSTER, Pa., Oct. 03, 2019 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a Hepatitis B Virus (HBV) therapeutic solutions company, today announced its decision to discontinue the clinical [...]

WW Announces Prepayment of Portion of Term Loan Facility

03/10/2019 - 22:20

NEW YORK, Oct. 03, 2019 (GLOBE NEWSWIRE) -- On October 3, 2019, WW International, Inc. (NASDAQ: WW) announced that it intends to voluntarily prepay $50 million in aggregate principal amount of term loans outstanding [...]

Novelion Therapeutics Announces Filing of Definitive Proxy Statement in Connection with Proposed Liquidation and Other Matters

04/10/2019 - 00:21

VANCOUVER, British Columbia, and CAMBRIDGE, Mass., Oct. 03, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN) (“Novelion” or the “Company”) today announced that it has filed its notice of meeting and [...]

Noushin Khoiny

04/10/2019 - 02:00

Dr. Noushin Khoiny discusses new California laws and how they will impact primary health care provider prescribing practices Long Beach, California, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Dr. Noushin Khoiny gave a talk on [...]

Parexel and HealthVerity Announce Strategic Partnership to Address Complex Clinical Research Questions with Customized Real-World Data Solutions

03/10/2019 - 18:00

Parexel customers now have access to data for more than 330 million patients that can be linked from more than 60 anonymized healthcare and consumer data sources BOSTON and PHILADELPHIA, Oct. 03, 2019 (GLOBE NEWSWIRE [...]

Molecular You Introduces New Precision Fitness Playbook: myFitnessFx™

03/10/2019 - 20:14

Takes the guesswork out of fitness programs with precision fitness metrics VANCOUVER, British Columbia, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Molecular You , the personalized health company, today announced the launch of [...]

ADMA Biologics Announces Poster Presentation at IDWeek 2019

03/10/2019 - 13:08

RAMSEY, N.J. and BOCA RATON, Fla., Oct. 03, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical and specialty immunoglobulin [...]

SIGA Completes Clinical Studies for IV Formulation of TPOXX®, NDA to be Submitted in 2020

03/10/2019 - 13:30

NEW YORK, Oct. 03, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it has reached concurrence [...]

vTv to Host Key Opinion Leader Event to Discuss the Type 1 Diabetes Treatment Landscape and Emerging Therapies as Adjuncts to Insulin

03/10/2019 - 13:30

HIGH POINT, N.C., Oct. 03, 2019 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), today announced that the Company will host a key opinion leader (KOL) presentation and webcast discussing the type 1 diabetes ( [...]

VIVUS Initiates Pay Down of Secured Debt and Announces Management Changes

03/10/2019 - 13:30

-Reduction of $48.6 million of Secured Debt will result in total interest savings of $10.5 million- -Organizational change streamlines commercial operations- CAMPBELL, Calif., Oct. 03, 2019 (GLOBE NEWSWIRE) -- VIVUS, [...]

Exactus, Inc. Launches E-Commerce Marketplace Through Exactushemp.com and Initiates Buy Back Program for Non-Traceable CBD Products

03/10/2019 - 13:48

DELRAY BEACH, Fla., Oct. 03, 2019 (GLOBE NEWSWIRE) -- Exactus, Inc. (OTCQB:EXDI) (the “Company”), an industrial hemp farm operator and manufacturer of hemp-derived phytocannabinoid products, today announced that it has [...]

MediPharm Labs Sets Date to Announce Third Quarter 2019 Financial Results

03/10/2019 - 13:49

TORONTO, Oct. 03, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation [...]

XBiotech annonce le premier patient dans une étude clinique visant à évaluer le bermekimab pour le traitement de la sclérose systémique

03/10/2019 - 13:53

Le bermekimab bloque la principale voie inflammatoire dans la sclérose systémique, une maladie dévastatrice, sans thérapie approuvée à l'heure actuelle AUSTIN, Texas, 03 oct. 2019 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ : [...]

Mesoblast Completes Successful Institutional Capital Raising of A$75 Million

03/10/2019 - 13:59

NEW YORK, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq: MESO; ASX: MSB), leader in cellular medicines for inflammatory diseases, announced today that it has successfully completed a A$75 million (US$50.4 [...]

Kaleido Biosciences Presents Ex Vivo Data of KB109 Demonstrating Reduction of Multi-drug Resistant Pathogens at IDWeek 2019™

03/10/2019 - 14:00

Additional Presentation on Platform at Upcoming Keystone Symposia on the Microbiome: Therapeutic Implications LEXINGTON, Mass., Oct. 03, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical- [...]

Tonix Pharmaceuticals Announces Completion of Long-Term Exposure Studies in Participants with PTSD to Evaluate the Tolerability of TNX-102 SL 5.6 mg

03/10/2019 - 14:00

Company Expects this Long-Term Safety Exposure Data to Satisfy Long-Term Exposure Requirements for Potential New Drug Applications for TNX-102 SL for PTSD and Fibromyalgia NEW YORK, Oct. 03, 2019 (GLOBE NEWSWIRE) -- [...]

Albireo Recognizes PFIC Awareness Day and Highlights Urgent Needs of Progressive Familial Intrahepatic Cholestasis Families

03/10/2019 - 14:00

Grassroots PFIC community advocates to build awareness of rare, life-threatening liver disease BOSTON, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (NASDAQ: ALBO), a clinical-stage orphan pediatric liver [...]

Spero Therapeutics Announces Positive Recommendation to Continue Phase 3 Clinical Trial of SPR994 as Planned Following Independent Review Committee Analysis of SPR994 Treated Patients in Lead-in Cohort of Trial

03/10/2019 - 14:00

CAMBRIDGE, Mass., Oct. 03, 2019 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in [...]

Catalyst Biosciences Provides DalcA Phase 2b Trial Update

03/10/2019 - 14:00

Two subjects have successfully completed dosing, exceeded the FIX activity efficacy endpoint and no anti-drug antibodies were detected SOUTH SAN FRANCISCO, Calif., Oct. 03, 2019 (GLOBE NEWSWIRE) -- Catalyst Biosciences [...]